Popular on s4story
- Filipino Poet Wins First International Poetry Prize at London's Bermondsey Festival
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach
- "The Godfather's Vow" by Antonino Scalabrino is published
- Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
- Rediscovered Christopher Lee Recording 'Elenore' Re-Released to Mark 10th Anniversary of His Passing
- Lottery.com Inc. Secures $300 Million in Growth Capital, Confirms Nasdaq Compliance & Acquires UAE Sports Incubator Amid High-Profile Brand Exposure
- History Matters: Book Recommendations for June
Similar on s4story
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Make Innovation Matter: Support H.R.1's R&D Expensing Relief for American Small Businesses
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
- Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide
- $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
- NUFABRX awarded Therapeutic Compression agreement with Premier, Inc
Intermountain Healthcare Implements DeepThink Health's Precision Intelligence Solutions to Manage its Molecular Tumor Board
S For Story/10429684
RICHMOND, Calif. - s4story -- DeepThink Health, Inc., a technology innovator in advanced analytics and artificial intelligence for precision medicine, announced today that Intermountain Healthcare is strengthening its cross-organizational Molecular Tumor Board with the adoption of DeepThink's Precision Tumor Board Solution.
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on S For Story
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on S For Story
- NEW CHILDREN'S BOOK RELEASE: "Mommy, Where Is My Daddy?" by Tracy L. Gray
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Mental and Emotional Self-Management, Practical Tools for Trauma-Informed Stress Management
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
Source: DeepThink Health
0 Comments
Latest on S For Story
- A Novel-in-verse Journey To Offer Hope In The Wake Of The Climate Crisis
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Kids Reading Adventures Launches Big Summer Book Sale on Smashwords Starting July 1!
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Make Innovation Matter: Support H.R.1's R&D Expensing Relief for American Small Businesses
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI)
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits
- New Novel From Essex Author Takes Readers on a Thrilling International Chase
- Kilpack's Dystopian Military Sci-Fi Novel Battle Calm Named Finalist in Utah Book Awards
- Anna D. Banks' Street Smart Series Soars: "Future Ready" Tops Charts, "Money Smart" Debuts #1
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- Anthony B. Bonapart Featured on the Cover of Entrepreneurs in the Spotlight Magazine
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
- Suzanne Harp named Managing Director in Texas, USA